Searched for
CLARIS STOCK
Claris completes sale of global injectables biz to BaxterThe company said it will now discuss with its advisors and identify the most efficient method of transferring a significant majority of the...- Claris-Baxter deal may be good news for investorsAnalysts said the company is likely to a sizeable one-time dividend or share buyback at higher levels.
- FIIs/FPIs restricted from buying more shares in Fortis, ClarisFIIs, NRIs and PIOs (Persons of Indian Origins) can invest in primary and secondary capital markets in India through Portfolio Investment S...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- Income-Tax Dept searches 20 premises of Claris LifesciencesIncome-Tax sleuths today conducted search and survey operations at around 20 commercial and residential premises of Claris Lifesciences, it...
- Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
- Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris promoter sells 12 lakh shares for over Rs 23 croreClaris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
- Claris receives US approval for two drugsClaris Lifesciences received approval for Ondensetron Injection used in prevention of nausea and vomiting during cancer chemotherapy.
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Claris Lifesciences Net Profit dips 27%, revenue down by 5%Claris Lifesciences Ltd, net profit dips successive for second time in a year. The net profit for the third quarter dropped by 27.34% and r...
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Adani group, Claris Lifesciences stock prices fall sharplyStock prices of Adani group companies and Claris Lifesciences fell sharply on Monday when the benchmark BSE Sensex closed 104 points lower.
- Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Morgan Stanley, Barclays buy Claris bulk shares in open market on USFDA clearanceClaris said it has formally received the letter from USFDA stating that it has completed its evaluation of the firm's corrective actions.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaitingThe consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences promoter offloads over 17 lakh sharesAditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold over 17.33 lakh shares of the drug company for Rs 28 cro...
- Claris Lifesciences yet to get USFDA clearanceClaris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- Citi offloads over 3 lakh shares of Claris LifesciencesForeign fund house Citigroup sold 3.19 lakh shares, worth about Rs 5 crore, of drug-maker Claris Lifesciences through an open market transa...
Load More
